{"id":"da-6034-5","safety":{"commonSideEffects":[{"rate":null,"effect":"Conjunctival hyperemia"},{"rate":null,"effect":"Iris pigmentation changes"},{"rate":null,"effect":"Eyelash growth"},{"rate":null,"effect":"Eye irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"DA-6034 is a prostamide analog designed for glaucoma and ocular hypertension treatment. It works by enhancing uveoscleral outflow of aqueous humor through prostaglandin F receptor agonism, thereby lowering intraocular pressure. The 5% formulation represents a topical ophthalmic solution for direct ocular administration.","oneSentence":"DA-6034 is a topical ophthalmic agent that reduces intraocular pressure and promotes aqueous humor outflow.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:30:51.336Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Glaucoma"},{"name":"Ocular hypertension"}]},"trialDetails":[{"nctId":"NCT01670357","phase":"PHASE2","title":"Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2012-04","conditions":"Dry Eye Syndrome","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DA-6034 High dose"],"phase":"phase_2","status":"active","brandName":"DA-6034 5%","genericName":"DA-6034 5%","companyName":"Dong-A ST Co., Ltd.","companyId":"dong-a-st-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DA-6034 is a topical ophthalmic agent that reduces intraocular pressure and promotes aqueous humor outflow. Used for Glaucoma, Ocular hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}